Host-directed therapies (HDTs) such as prednisolone and pentoxifylline have also demonstrated trends towards reducing levels of tumor necrosis factor-alpha, a key pro-inflammatory cytokine involved in TB pathogenesis [71,72]. The gene discussed is TNF; the disease is tuberculosis.